Cited by 324SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesRespiratory viral infections research

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Recent endemic coronavirus infection is associated with less severe COVID-19

Open access

Sagar, Manish, Reifler, Katherine, Rossi, Michael, Miller, Nancy S., Sinha, Pranay, White, Laura F., Mizgerd, Joseph P.·2021·Journal of Clinical Investigation

DOI 10.1172/jci143380PMC PMC7773342

Open this paper in CoChat — free account Open PDF

Abstract

Four different endemic coronaviruses (eCoVs) are etiologic agents for the seasonal common cold, and these eCoVs share extensive sequence homology with human SARS coronavirus 2 (SARS-CoV-2). Here, we show that individuals with, as compared with those without, a recent documented infection with eCoV were tested at greater frequency for respiratory infections but had a similar rate of SARS-CoV-2 acquisition. Importantly, the patients with a previously detected eCoV had less-severe coronavirus disease 2019 (COVID-19) illness. Our observations suggest that preexisting immune responses against endemic human coronaviruses can mitigate disease manifestations from SARS-CoV-2 infection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci143380

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984
Prevalence of Asymptomatic SARS-CoV-2 Infection
Oran, D. P., & Topol, E. J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3012 · Cited by 2,348
Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, march 1-30, 2020
Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., Prill, M., Chai, S. J., Kirley, P. D., Alden, N. B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e3 · Cited by 2,335
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
Jain, S., Self, W. H., Wunderink, R. G., Fakhran, S., Balk, R., Bramley, A. M., Reed, C., Grijalva, C. G., Anderson, E. J., Courtney, D. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500245 · Cited by 2,323
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887

Flagged first, then by citations

Show all 20 references

Research works printed but not linked: 1

10.1016/j.medj.2020.05 · DOI

Sorted by citations

Items 201–300 of 310

Cross-reactive cellular, but not humoral, immunity is detected between OC43 and SARS-CoV-2 NPs in people not infected with SARS-CoV-2: Possible role of cTFH cells
García-Jiménez, Á. F., Cáceres-Martell, Y., Fernández‐Soto, D., Martínez‐Fleta, P., Casasnovas, J. M., Sánchez‐Madrid, F., Frade, J. M. R., Valés‐Gómez, M., & Reyburn, H. T. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4covcra0721-356rrr · Cited by 6
The Journal of Clinical Investigation in the time of COVID-19
Casadevall, A., Jackson, S., Semenza, G. L., Tomaselli, G. F., & Ahima, R. S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci156409 · Cited by 6
Viral Epitope Scanning Reveals Correlation between Seasonal HCoVs and SARS-CoV-2 Antibody Responses among Cancer and Non-Cancer Patients
Lidenge, S. J., Yalcin, D., Bennett, S. J., Ngalamika, O., Kweyamba, B. B., Mwita, C. J., Tso, F. Y., Mwaiselage, J. D., West, J. T., & Wood, C. A. (2024) · Viruses · doi:10.3390/v16030448 · Cited by 5
T-cell responses to SARS-CoV-2 in unexposed South African women
Nunes, M. C., Johnson, M. J., Kwatra, G., Weinberg, A., & Madhi, S. A. (2021) · Gates Open Research · doi:10.12688/gatesopenres.13373.2 · Cited by 5
Association between the Seroprevalence of Antibodies against Seasonal Alphacoronaviruses and SARS-CoV-2 Humoral Immune Response, COVID-19 Severity, and Influenza Vaccination
Brydak, L. B., Sikora, D., Poniedziałek, B., Hallmann, E., Szymański, K., Kondratiuk, K., & Rzymski, P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051733 · Cited by 5
Minding the margins: Evaluating the impact of COVID-19 among Latinx and Black communities with optimal qualitative serological assessment tools
Binder, R. A., Matta, A. M., Forconi, C. S., Oduor, C. I., Bedekar, P., Patrone, P. N., Kearsley, A. J., Odwar, B., Batista, J., Forrester, S., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307568 · Cited by 5
COVID-19 and immunity: quo vadis?
Miyasaka, M. (2021) · International Immunology · doi:10.1093/intimm/dxab008 · Cited by 5
Vaccines beyond antibodies
King, A. (2021) · EMBO Reports · doi:10.15252/embr.202154073 · Cited by 5
Is There a Relationship Between ADHD and COVID-19 Prevalence and Mortality Indices? An Analysis of Data From 156 Countries
Rajkumar, R. P. (2021) · Journal of Attention Disorders · doi:10.1177/10870547211056894 · Cited by 5
Cellular immunity in patients with COVID-19: molecular biology, pathophysiology, and clinical implications
Sсherbak, S. G., Vologzhanin, D. A., Голота, А. С., Kamilova, Т. A., & Макаренко, С. В. (2022) · Journal of clinical practice · doi:10.17816/clinpract106239 · Cited by 5
Previous exposure to common coronavirus HCoV-NL63 is associated with reduced COVID-19 severity in patients from Cape Town, South Africa
Lesmes-Rodríguez, L. C., Lambarey, H., Chetram, A., Riou, C., Wilkinson, R. J., Joyimbana, W., Jennings, L., Orrell, C., Hernández, D. A. J., & Schäfer, G. (2023) · Frontiers in Virology · doi:10.3389/fviro.2023.1125448 · Cited by 5
Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study
Lawal, B. J., Gallagher, K. E., Kitonsa, J., Tindanbil, D., Kasonia, K., Drammeh, A., Lowe, B. S., Mukadi‐Bamuleka, D., Patterson, C., Greenwood, B. M., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.03.049 · Cited by 5
Vaccination with BNT162b2 and ChAdOx1 nCoV-19 Induces Cross-Reactive Anti-RBD IgG against SARS-CoV-2 Variants including Omicron
Gerges, D., Kapps, S., Hernández-Carralero, E., Freire, R., Aiad, M., Schmidt, S., Winnicki, W., Reiter, T., Pajenda, S., Schmidt, A., et al. (2022) · Viruses · doi:10.3390/v14061181 · Cited by 5
Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals
Adami, F. L., de Castro, M. V., Almeida, B. D. S., Daher, I. P., Yamamoto, M. M., Santos, K. S., Zatz, M., Naslavsky, M. S., Rosa, D. S., Cunha‐Neto, E., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1396603 · Cited by 4
Interactions between zoonotic pathogens and infectious disease spread: Why understanding mechanisms and modelling matters more than ever
Li, N., Ruan, S., & Tian, H. (2025) · Biosafety and Health · doi:10.1016/j.bsheal.2025.07.008 · Cited by 4
Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China
Luo, Y., Lv, H., Zhao, S., Sun, Y., Liu, C.-Y., Chen, C., Liang, W., Kwok, K. O., Teo, Q. W., So, R. T. Y., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.11.044 · Cited by 5
A Serological Multiplexed Immunoassay (MIA) Detects Antibody Reactivity to SARS-CoV-2 and Other Viral Pathogens in Liberia and Is Configurable as a Multiplexed Inhibition Test (MINT)
Haun, B. K., To, A., Williams, C. A., Ball, A. H., Fong, K., Wong, T. A. S., Shobayo, B. I., Teahton, J., Ching, L. L., Kamara, V., et al. (2024) · Immuno · doi:10.3390/immuno4010007 · Cited by 4
Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity
Stanley, A. M., Aksyuk, A. A., Wilkins, D. E., Green, J. A., Lan, D., Shoemaker, K., Tieu, H., Sobieszczyk, M. E., Falsey, A. R., & Kelly, E. J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1401728 · Cited by 4
Vaccination against SARS-CoV-2 provides low-level cross-protection against common cold coronaviruses in mouse and non-human primate animal models
Naghibosadat, M., Babuadze, G. G., Pei, Y., Hurst, J. R., Salvant, E., Gaete, K., Biondi, M. J., Moloo, B., Goldstein, A., Avery, S., et al. (2025) · Journal of Virology · doi:10.1128/jvi.01390-24 · Cited by 5
Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies
Bean, D. J., Liang, Y. M., Avila, F., He, X., Asundi, A., & Sagar, M. (2025) · Journal of Virology · doi:10.1128/jvi.00550-25 · Cited by 4
Self-citation
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP
Gao, C. A., Pickens, C. I., Morales‐Nebreda, L., & Wunderink, R. G. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1759889 · Cited by 4
Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity
Duette, G., Lee, E., Gomes, G. M. C., Tungatt, K., Doyle, C. M., Stylianou, V. V., Lee, A., Maddocks, S., Taylor, J., Khanna, R., et al. (2023) · ImmunoHorizons · doi:10.4049/immunohorizons.2300034 · Cited by 4
Low pre-existing endemic human coronavirus (HCoV-NL63)-specific T cell frequencies are associated with impaired SARS-CoV-2-specific T cell responses in people living with HIV
Nguni, T. L., Musale, V., Nkosi, T., Mandolo, J. J., Mvula, M., Michelo, C. M., Karim, F., Moosa, M. Y. S., Khan, K., Jambo, K., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1291048 · Cited by 4
Comparable endemic coronavirus nucleoprotein‐specific antibodies in mild and severe Covid‐19 patients
Leach, S., Harandi, A. M., Bergström, T. B., Andersson, L., Nilsson, S., van der Hoek, L., & Gisslén, M. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27038 · Cited by 4
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease
Fedele, G., Russo, G., Schiavoni, I., Leone, P., Olivetta, E., Perri, V., Zingaropoli, M. A., Ciardi, M. R., Pasculli, P., Mastroianni, C. M., et al. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115586 · Cited by 4
Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection
Sim, K.-Y., Ko, G.-H., Bae, S.-E., Choi, K. Y., Lee, J. S., Kim, B. C., Lee, K. H., Song, M., & Park, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.813240 · Cited by 4
The immunopathogenesis of SARS ‐CoV‐2 infection in children: diagnostics, treatment and prevention
Patel, H., McArdle, A. J., Seaby, E. G., Levin, M., & Whittaker, E. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1405 · Cited by 5
Refocus on Immunogenic Characteristics of Convalescent COVID-19 Challenged by Prototype SARS-CoV-2
Huang, X., Liang, C., Li, M., Chen, H., Li, Z., Ruan, Q., Hu, X., Zeng, L., Lin, H., Zhao, W., et al. (2023) · Vaccines · doi:10.3390/vaccines11010123 · Cited by 4
Performance of T-Track® SARS-CoV-2, an Innovative Dual Marker RT-qPCR-Based Whole-Blood Assay for the Detection of SARS-CoV-2-Reactive T Cells
Kanis, F. M., Meier, J. P., Guldan, H., Niller, H.-H., Dahm, M., Dansard, A., Zander, T., Struck, F., Soutschek, E., Deml, L., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13172722 · Cited by 3
Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunity
Florian, D. M., Bauer, M. W., Popovitsch, A., Faé, I., Springer, D. N., Graninger, M., Traugott, M. T., Weseslindtner, L., Aberle, S. W., Fischer, G., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1501704 · Cited by 4
Potential use of endemic human coronaviruses to stimulate immunity against pathogenic SARS-CoV-2 and its variants
Shamabadi, N. S., Bagasra, A. B., Pawar, S., & Bagasra, O. (2023) · Libyan Journal of Medicine · doi:10.1080/19932820.2023.2209949 · Cited by 3
Development of a cross-protective common cold coronavirus vaccine
Dangi, T., Li, S., & Penaloza‐MacMaster, P. (2025) · Journal of Virology · doi:10.1128/jvi.01526-25 · Cited by 3
Family matters for coronavirus disease and vaccines
Bean, D. J., & Sagar, M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci155615 · Cited by 3
Self-citation
Divergent SARS-CoV-2-specific T cell responses in intensive care unit workers following mRNA COVID-19 vaccination
del Riego, E. S., Sáiz, M. L., Corte-Iglesias, V., Gordillo, B. L., Martín-Martín, C., Rodríguez-Pérez, M., Escudero, D., López‐Larrea, C., & Suárez-Álvarez, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.942192 · Cited by 3
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination
Casado, J. L., Vizcarra, P., Martín-Hondarza, A., Blasco, M., Platero, M. G., Häemmerle, J., Fernández-Escribano, M., & Vallejo, A. (2023) · Viruses · doi:10.3390/v15030627 · Cited by 4
Increased COVID-19 Mortality and Deficient SARS-CoV-2 Immune Response Are Not Associated with Higher Levels of Endemic Coronavirus Antibodies
Adhikari, B., Oltz, E. M., Bednash, J. S., Horowitz, J. C., Amimo, J. O., Raev, S. A., Fernández, S., Anghelina, M. I., Liu, S., Rubinstein, M. P., et al. (2023) · Immuno · doi:10.3390/immuno3030020 · Cited by 3
An evaluation of patients with a previous endemic coronavirus infection during the COVID‐19 pandemic
Otlu, B., Yakupoğulları, Y., Tanrıverdi, E. S., & Bayındır, Y. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26942 · Cited by 3
Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients
Yamashita, T., Shimakami, T., Nio, K., Terashima, T., Okajima, M., Taniguchi, T., Wada, T., Honda, M., Gabata, T., Ota, K., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133870 · Cited by 3
Convalescent Plasma for Covid-19
Sullivan, D. J., Gebo, K. A., & Hanley, D. F. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2208338 · Cited by 3
Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment
Karaba, A. H., Johnston, T. S., Beck, E. J., Laeyendecker, O. B., Cox, A. L., Klein, S. L., Sullivan, D. J., Meisenberg, B. R., Abinante, M., Oei, K., et al. (2023) · mBio · doi:10.1128/mbio.03287-22 · Cited by 2
A brief history of the COVID-19 pandemic: perspectives in risk science and data analytics
Trump, B. D., Keenan, J. M., & Linkov, I. (2025) · Journal of Risk Research · doi:10.1080/13669877.2025.2569437 · Cited by 2
Prevalence of Common Human Coronaviruses (NL63, 229E, and OC43) in Adults before the COVID-19 Pandemic: a Single-Center Study from Turkey, 2015–2020
Sönmezer, M. Ç., Şahin, T. K., Erul, E., Dizman, G. T., İnkaya, A. Ç., Alp, A., Alp, Ş., & Ünal, S. (2022) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2022.255 · Cited by 2
HCoV-NL63 and HCoV-HKU1 seroprevalence and its relationship with the clinical features of COVID-19 patients from Villavicencio, Colombia
Lesmes-Rodríguez, L. C., Castillo, L. N. P., & Hernández, D. A. J. (2024) · Biomédica · doi:10.7705/biomedica.7168 · Cited by 2
Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection
Soni, M., Migliori, E., Assal, A., Chan, H. T., Ciubotariu, R., Pan, J., Cicero, K. I., Pereira, M. R., Mapara, M. Y., & Muranski, P. J. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.05.005 · Cited by 2
Transcriptomic analysis of asymptomatic and symptomatic severe Turkish patients in SARS-CoV-2 infection
Pençe, S. (2022) · Northern Clinics of Istanbul · doi:10.14744/nci.2022.28000 · Cited by 2
epiDAMIK 6.0: The 6th International Workshop on Epidemiology meets Data Mining and Knowledge Discovery
Adhikari, B., Rodríguez, A., Yadav, A., Pei, S., Srivastava, A., Charpignon, M., Vullikanti, A. K. S., & Prakash, B. A. (2023) · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/3580305.3599220 · Cited by 2
Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of the Congo
Mitangala, P. N., Irenge, L. M., Musubao, E. T., Mbeva, J.-B. K., Ayonga, P. N., Safari, I. K., Bonane, J. K., Ntabe, E. N., Senga, R. K. K., Mutombo, G. N., et al. (2023) · Epidemiology and Infection · doi:10.1017/s0950268823001498 · Cited by 2
SARS-CoV-2 cellular and humoral responses in vaccine-naive individuals during the first two waves of COVID-19 infections in the southern region of The Netherlands: a cross-sectional population-based study
Hanssen, D. A. T., Arts, K., Nix, W. H. V., Sweelssen, N. N. B., Welbers, T. T. J., de Theije, C. C., Wieten, L., Pagen, D. M. E., Brinkhues, S., Penders, J., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00126-24 · Cited by 2
Does Prior Respiratory Viral Infection Provide Cross-Protection Against Subsequent Respiratory Viral Infections? A Systematic Review and Meta-Analysis
Gopal, V., Koh, M. C. Y., Ngiam, J. N., Hang-Cheng, O., Somani, J., Tambyah, P. A., & Tey, J. C. S. (2024) · Viruses · doi:10.3390/v16060982 · Cited by 2
High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines
Joseph, J. O., Ylade, M. C., Daag, J. V., Aogo, R. A., Crisostomo, M. V., Mpingabo, P. I., Premkumar, L., Deen, J. L., & Katzelnick, L. C. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09672-8 · Cited by 2
Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity
Guzmán-Martínez, O., Guardado, K., Cardoso, M. V., Trujillo-Rivera, A., Gómez-Ñañez, I., León, M. C. O., Espinosa, R., Ramos, C., Pérez‐Carreón, J. I., López-Guerrero, D. V., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18179058 · Cited by 2
SARS-CoV-2 mechanisms of action and impact on human organism, risk factors and potential treatments. An exhaustive survey
Carro, B. (2021) · All Life · doi:10.1080/26895293.2021.1977186 · Cited by 2
Attitudinal analysis of vaccination effects to lead endemic phases
Ku, D., Kim, G., Peck, K. R., Park, I. K., Chang, R., Kim, D., & Lee, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-37498-y · Cited by 2
Do patients infected with human coronavirus before the COVID-19 pandemic have less risk of being infected with COVID-19?
İŞBİLEN, G. Ş., Uysal, A. A., Yiğit, S., Appak, Ö., Sipahi, H., Bozdayı, G., Sayıner, A., Çiçek, C., Tunçcan, Ö. G., & Sıpahı, O. R. (2024) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.55730/1300-0144.5846 · Cited by 2
Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
Muthumani, K., Xu, Z., Jeong, M., Maslow, J. N., Kalyanaraman, V. S., & Srinivasan, A. (2021) · Translational Medicine Communications · doi:10.1186/s41231-021-00093-2 · Cited by 3
Human Challenge Studies with Coronaviruses Old and New
McKendry, R., Lemm, N., Papargyris, L., & Chiu, C. (2021) · Current topics in microbiology and immunology · doi:10.1007/82_2021_247 · Cited by 1
T cell responses to SARS-COV-2
Khadri, L., Ziraksaz, M. H., Barekzai, A. B., & Ghauri, B. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.06.001 · Cited by 1
Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses
Zhang, B., Liu, Y., Chen, T., Lai, J., Liu, S., Liu, X., Zhu, Y., Rao, H., Peng, H., & Ma, X. (2025) · Vaccines · doi:10.3390/vaccines13111168 · Cited by 2
Common human coronavirus-induced cross-reactive salivary antibodies exhibit neutralizing activity and protective potential against SARS-CoV-2
Ou‐Yang, P., Chuang, M., Jann-Tay, W., Sheng, W., Jung, C., & Chia, J. (2025) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2025.12.004 · Cited by 1
Pre-COVID-19 ex vivo cross-reactive IFN-γ cellular response to SARS-CoV-2 spike overlapping peptides is more prevalent among Kenyan compared to Swedish adults
Wanjiku, P., Orindi, B., Mwacharo, J. K., Chemweno, J., Karanja, H., Kronsteiner, B., Kai, O. K., Wright, D., Ochola‐Oyier, L. I., Sundling, C., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-12582-6 · Cited by 1
Seroprevalence of endemic and emergent coronaviruses among SARS-COV-2 patients and healthcare workers in Abidjan, Côte d’Ivoire
Menezes, A., Koffi, D., Rice, B. L., Metcalf, C. J. E., Graham, A. L., Cauchemez, S., Peeters, M., Toure, A. O., Dosso, M., Ayouba, A., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13133-9 · Cited by 1
SARS-CoV-2-identical protein regions found in mammalian coronaviruses have immunogenic potential and can imply cross-protection
Lopes, L. R. (2024) · ImmunoInformatics · doi:10.1016/j.immuno.2024.100034 · Cited by 1
Sex differences in pneumonia risk during COVID-19 in Mexico
Venegas-Ramírez, J., Mendoza‐Cano, O., Trujillo, X., Huerta, M., Ríos‐Silva, M., Lugo-Radillo, A., Bricio‐Barrios, J. A., Cuevas-Arellano, H. B., Uribe-Ramos, J. M., Solano-Barajas, R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-78200-0 · Cited by 1
Systematic assessment of COVID-19 host genetics using whole genome sequencing data
Schmidt, A., Casadei, N., Brand, F., Demidov, G., Vojgani, E., Abolhassani, A., Aldisi, R. S., Butler‐Laporte, G., DeCOI host genetics group, Alawathurage, T. M., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012786 · Cited by 1
Patients With Mild COVID-19 Exhibit Low Functional Avidity of SARS-CoV-2 Membrane Protein-Reactive CD4+ T Cells
Kim, A. R., Koh, J., Rha, M., Jung, J., Ko, J., Choi, H. K., Jeon, J. H., Seok, H., Park, D. W., Peck, K. R., et al. (2025) · Immune Network · doi:10.4110/in.2025.25.e4 · Cited by 1
Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection
Weigl, N., Pleimelding, C., Gilberg, L., Huynh, D., Brand, I., Bruger, J., Frese, J., Eser, T. M., Ahmed, M. I. M., Noller, J. M. G., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325923 · Cited by 1
Prepandemic levels of cytokines and immunoglobulins and risk of SARS-CoV-2 infection and COVID-19 in the general population of Barcelona
Porta, M. S., Pumarega, J. A., Aguilar, R., Prieto‐Merino, D., Campi, L., Rius, C., Villar-García, J., Vidal, M., Jiménez, A., Peña‐Fernández, A., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1548456 · Cited by 1
Seasonal Coronavirus Pneumonia After SARS-CoV-2 Infection and Vaccination: New Frenemies?
Buckley, R. D. M., Díaz‐Menéndez, M., García‐Rodríguez, J., & Arribas, J. R. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab421 · Cited by 1
Mucosal antibody response and SARS‐CoV‐2 shedding in patients with COVID‐19 related olfactory dysfunction
Sharma, S., Thiriard, A., Olislagers, V., Lechien, J. R., Jurion, M., Delforge, M., Marchant, A., & Saussez, S. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29398 · Cited by 1
Reply to Ringlander et al
Schnierle, B. S. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab090 · Cited by 1
SARS coronavirus vaccines protect against different coronavirusesPreprint
Dangi, T., Palacio, N. M., Sanchez, S., Class, J., Visvabharathy, L., Ciucci, T., Koralnik, I. J., Richner, J. M., & Penaloza‐MacMaster, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.01.446491 · Cited by 1
Asymptomatic SARS-CoV-2 infections tend to occur less frequently in developed nationsPreprint
Chowdhury, S., Tiwari, A., James, A., Chatterjee, B., & Dixit, N. M. (2023) · medRxiv · doi:10.1101/2023.12.14.23299954 · Cited by 1
Bioinformatic identification of Endemic Coronaviruses’ epitopes in SARS-CoV-2 genomes isolated in KenyaPreprint
Mbogori, E., Musyoki, S., Biegon, R., & Patel, K. T. (2024) · Research Square · doi:10.21203/rs.3.rs-4402197/v1 · Cited by 1
The characterisation of human coronavirus nl63 proteins
Gordon, B. (2021) · University of the Western Cape Electronic Theses and Dissertations Repository (University of the Western Cape)
Application of Pandemic Intelligence in Dynamic Data in Taiwan
Chang, T.-Y., Su, W.-R., Chen, H., Huang, M.-W., & Chen, L. A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18189925
The impact of environmental mycobiomes on geographic variation in COVID-19 mortalityPreprint
Ladau, J., Abuabara, K., Walker, A. M., Joachimiak, M. P., Bansal, I., Wu, Y., Hoffman, E. B., Kuo, C., Falco, N., Streich, J., et al. (2021) · medRxiv · doi:10.1101/2021.12.14.21267549
SARS-CoV-2 on the move: Reviewing Innate vs Acquired for Covid-19Preprint
Banerjee, S. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/j2ws5
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease
Fedele, G., Russo, G., Schiavoni, I., Leone, P., Olivetta, E., Perri, V., Zingaropoli, M. A., Ciardi, M. R., Pasculli, P., Mastroianni, C. M., et al. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115539
Estimation of COVID-19 Antibody (IgG) Titer Among Fully Vaccinated, Partially Vaccinated and Non-vaccinated Individuals in a Tertiary Care Hospital in Eastern India
Das, A., Neogi, A., Banerjee, P., Sengupta, S., & Kundu, M. (2022) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2022.05.1117
Deciphering the Covid‐19 Epidemic and Analysis of Its Controllability
Salgues, B., & Barnouin, J. (2022) · Wiley eBooks · doi:10.1002/9781394163755.ch1
The Influence of Pre-Existing Immunity against Human Common Cold Coronaviruses on COVID-19 Susceptibility and Severity
Tarazona, E. D. L. T., Jiménez, D., Marcos-Mencía, D., Mendieta-Baro, A., Rivera-Delgado, A., Romero‐Hernández, B., Muriel, A., Rodríguez-Domínguez, M., Villar, S. S., & Moreno, S. (2023) · Microbiology Research · doi:10.3390/microbiolres14030093
Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Siberian Populations
Shaprova, O. N., Васильевич, Ш. Д., Kolosova, E. A., Borisevich, S. S., Soroka, A. A., Merkuleva, I. A., Nikitin, A. O., Volosnikova, E. A., Ushkalenko, N. D., Zaykovskaya, A. V., et al. (2023) · Antibodies · doi:10.3390/antib12040082
Prevalência e reatividade cruzada entre SARS-CoV-2 e HCoVs endêmicos
Lima, A. C. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2023.tde-07122023-181214
Prevalence of Children and Adolescents with Asymptomatic Covid-19 and its Implications in Pediatrics and General Medicine
Turabián, J. L. (2021) · Epidemiology International Journal · doi:10.23880/eij-16000s1-017
Differential patterns of antibody response against SARS-CoV-2 nucleocapsid epitopes detected in sera from patients in the acute phase of COVID-19, convalescents, and pre-pandemic individuals
Razim, A., Pacyga-Prus, K., Kazana, W., Zabłocka, A., Macała, J., Ciepłucha, H. D., Gamian, A., & Górska, S. (2024) · Pathogens and Disease · doi:10.1093/femspd/ftae025
A life course approach to health in the age of pandemics
Kuh, D. J., Blodgett, J. M., Lipkin, W. I., & Susser, E. (2025) · Oxford University Press eBooks · doi:10.1093/oso/9780198895961.003.0002
Minimal Impact of Prior Common Cold Coronavirus Exposure on Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination or Infection Risk in Older Adults in Congregate Care
Breznik, J. A., Cowbrough, B., Bilaver, L., Dushoff, M., Stacey, H. D., Ang, J. C., Clare, R., Kennedy, A. E., Costa, A. P., Nazy, I., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf178 · Cited by 1
Circulating Antibodies Against Common Cold Coronaviruses Do Not Interfere with Immune Responses to Primary or Booster SARS-CoV-2 mRNA Vaccines
Adhikari, B., Oltz, E. M., Gumina, R. J., Kick, M. K., Saif, L. J., & Vlasova, A. N. (2025) · Vaccines · doi:10.3390/vaccines13050547
Common Cold Coronavirus Test Positivity Decreased After Widespread SARS-CoV-2 Experience
Parayil, T., Monroe, J., Bean, D. J., & Sagar, M. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf326 · Cited by 1
Self-citation
SARS-CoV-2 and HCoV IgG Antibodies in the Breast Milk of a Postpartum SARS-CoV-2 Patient Following Bamlanivimab Administration: A Case Report
Tanunliong, G., Condin, C., Márquez, A. C., Li, S., Binning, N., Gibson, M., Griffiths, B., Wright, A. J., Money, D., Krajden, M., et al. (2025) · COVID · doi:10.3390/covid5080123
Humoral immunity to endemic coronaviruses in older adults increases post-COVID-19 vaccination and in correlation with their anti-SARS-CoV-2 responsesPreprint
Woodward, S. E., McMillan, B., Gaultier, G. N., Márquez, A. C., Valadbeigy, T., Simmons, K., Nikiforuk, A. M., Bartlett, S., Sekirov, I., Morshed, M. G., et al. (2025) · medRxiv · doi:10.1101/2025.08.26.25334476
Cross‐Reactivity of SARS ‐ CoV ‐2 Antibodies With Typhoid Flagellar‐H Protein
Pasha, A., & Saeed, M. (2025) · Tropical Medicine & International Health · doi:10.1111/tmi.70027 · Cited by 1
Immune signatures of SARS-CoV-2 infection resolution in human lung tissues
Kenney, D., O’Connell, A. K., Tseng, A. E., Turcinovic, J., Sheehan, M. L., Nitido, A. D., Montanaro, P., Gertje, H. P., Ericsson, M., Connor, J. H., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013469
Tracking SARS-CoV-2 seroprevalence in frontline healthcare workers at the beginning of COVID-19 pandemic and reliability of serological laboratory interpretation: a prospective cohort study
Sewatanon, J., Sukapirom, K., Boonarkart, C., Auewarakul, P., Niyomnaitham, S., Pattanapanyasat, K., Chokephaibulkit, K., & Angkasekwinai, N. (2025) · Virology Journal · doi:10.1186/s12985-025-02960-y
Serological evaluation of coronavirus IgA and IgG antibodies in a repeated cross-sectional cohort of unvaccinated and vaccinated pregnant individuals over three months following SARS-CoV-2 infection
Tanunliong, G., Márquez, A. C., Sbihi, H., Pidduck, T., Chang, Y. X., Li, F. F., Luk, D., Forward, L., McClymont, E., Elwood, C. N., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02167-25
Endemic penetrance of SARS-CoV-2 has impacted marginally on immunity to spike protein of human coronaviruses
Lancaster, T., Tut, G., Sylla, P., Bone, D., Bentley, C., Spalkova, E., Jadir, A., Bruton, R. K., Spencer, K., Mallick, S., et al. (2026) · Communications Biology · doi:10.1038/s42003-025-09474-x
Development of seropositivity to SARS-CoV-2 over the course of the COVID-19 pandemic in adolescents in a longitudinal cohort study in Cebu, Philippines
Daag, J. V., Magsakay, G. L., Blanco, S., Daque, M. G. N., Lobitaña, I., Lariana, M. A., Florendo, K. L., Crisostomo, M. V., Escoto, A. C., Premkumar, L., et al. (2026) · PLOS Global Public Health · doi:10.1371/journal.pgph.0005961
Protective Association of Endemic HCoV-NL63 With Symptomatic COVID-19 in a Pediatric Cohort
Kakuya, F., Saisho, Y., Terao, R., Okubo, H., Fujiyasu, H., INYAKU, F., & Kinebuchi, T. (2026) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000005200
Development and persistence of memory immune recall response following SARS-CoV-2 infection in children
El-Orfali, Y., Mansour, R., Alkalamouni, H., Khawaja, G., & Massaad, M. J. (2026) · Clinical Immunology · doi:10.1016/j.clim.2026.110689
Cross‐Reactive IgG Antibody Responses to SARS‐CoV‐2 in Older Adults Following Seasonal Coronavirus Infection in Jiangsu, China (2015–2017)
Xiao, C., Leung, N., Ling, S., Lin, X., Chen, Y., Xie, Y., Peiris, M. J. S., Zanin, M., Cowling, B. J., & Wong, S. (2026) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.70250

Authors: Sagar, M., Reifler, K., Rossi, M., Miller, N. S., Sinha, P., White, L. F., & Mizgerd, J. P.
Affiliations: Boston University (US)
Corresponding author: Sagar, Manish
Mizgerd, Joseph P.
ORCID: Sagar, Manish
Reifler, Katherine
Miller, Nancy S.
Sinha, Pranay
White, Laura F.
Mizgerd, Joseph P.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2021-01-04
Volume: 131
Issue: 1
ISSN: 0021-9738 (ISSN-L)
1558-8238
DOI: 10.1172/jci143380
PMC: PMC7773342
OpenAlex: W3090049663
Cited by: 324
References: 20
Citations by year: 2026: 13 · 2025: 28 · 2024: 32 · 2023: 59 · 2022: 77 · 2021: 109
FWCI: 8.19
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (HL-135756, AI-145661, AI-052074, GM-122876)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords: endemic coronaviruses, SARS-CoV-2, COVID-19 severity, pre-existing immunity, cross-protection, common cold, immune response
MeSH terms: COVID-19, SARS-CoV-2, Adult, Aged, Antibodies, Viral, Female, Humans, Male, Middle Aged, Severity of Illness Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Recent endemic coronavirus infection is associated with less severe COVID-19

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks